CymaBay Therapeutics Inc. (CBAY) Social Stream



CymaBay Therapeutics Inc. (CBAY): $3.89

-0.12 (-2.99%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CBAY to Watchlist
Sign Up

Industry: Biotech


Ranked

of 509

in industry

CymaBay Therapeutics Inc (CBAY) Price Targets From Analysts

Use the tables below to see what analysts covering CymaBay Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
10 $14 $7 $10.8 $4.1 163.41%

The Trend in the Analyst Price Target


Over the past 86 days, CBAY's average price target has gone down $0.84.

Over the past 16 months, CBAY's average upside potential has been 147.53%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-15 10 14 7 10.80 3.80 184.21%
2021-09-11 10 14 7 10.80 3.89 177.63%
2021-08-09 10 15 7 11.50 3.89 195.63%
2021-08-07 10 15 7 11.50 3.93 192.62%
2021-08-05 10 15 7 11.50 3.93 192.62%
2021-08-01 11 15 7 11.64 3.94 195.43%
2021-07-24 11 15 7 11.64 4.13 181.84%
2021-06-21 11 15 7 11.64 4.72 146.61%
2021-06-13 10 15 7 12.00 4.68 156.41%
2021-04-26 10 15 7 12.00 4.65 158.06%
2021-04-25 10 15 7 12.00 4.44 170.27%
2021-03-23 10 20 10 13.40 4.78 180.33%
2021-03-20 10 20 10 13.40 5.02 166.93%
2021-02-01 11 20 10 13.09 5.65 131.68%
2021-01-30 11 20 10 13.09 5.35 144.67%
2021-01-23 11 20 10 13.09 5.88 122.62%
2020-11-26 11 20 9 13.00 7.26 79.06%
2020-11-22 11 20 9 13.00 7.77 67.31%
2020-11-07 11 20 9 13.00 7.85 65.61%
2020-10-25 11 20 8 12.73 9.03 40.97%
2020-09-28 11 20 8 12.73 NA NA%
2020-09-08 10 20 8 12.80 NA NA%
2020-08-24 10 20 8 12.40 NA NA%
2020-08-21 9 20 8 12.78 NA NA%
2020-08-11 10 20 7 12.20 NA NA%
2020-08-03 10 20 7 11.90 NA NA%
2020-07-22 9 15 6 9.56 NA NA%
2020-06-22 9 15 6 8.78 NA NA%
2020-06-16 10 15 6 9.40 NA NA%
2020-06-13 10 15 6 9.40 NA NA%
2020-05-28 10 15 6 9.40 NA NA%

CBAY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.35 3 7 0 0 0 10

The Trend in the Broker Recommendations


Over the past 19 months, CBAY's average broker recommendation rating improved by 0.63.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • CBAY has a higher upside potential (average analyst target price relative to current price) than 87.32% of all US stocks.
  • The variance in analysts' estimates of CBAY is lower than 14.96% of all US stocks.
  • CymaBay Therapeutics Inc's number of analysts covering the stock is higher than 98.45% of stocks in the small market cap category.
  • CBAY has a greater average analyst price target than 20.36% of all US stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CymaBay Therapeutics Inc are FLXN, VKTX and ATAI.

What is the outlook for CBAY? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7625 seconds.